ImportRefusal LogoImportRefusal

REYOUNG PHARCEUTICAL CO LTD

⚠️ High Risk

FEI: 3040487740 • San Pedro • HONDURAS

FEI

FEI Number

3040487740

📍

Location

San Pedro

🇭🇳

Country

HONDURAS
🏢

Address

Para Farmaceu Tica, , San Pedro, , Honduras

High Risk

FDA Import Risk Assessment

62.5
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

2
Total Refusals
1
Unique Violations
11/10/2025
Latest Refusal
11/10/2025
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
17.7×30%
Recency
96.2×20%
Frequency
20.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
11/10/2025
56BBA03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/10/2025
62GAA41IBUPROFEN (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is REYOUNG PHARCEUTICAL CO LTD's FDA import refusal history?

REYOUNG PHARCEUTICAL CO LTD (FEI: 3040487740) has 2 FDA import refusal record(s) in our database, spanning from 11/10/2025 to 11/10/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. REYOUNG PHARCEUTICAL CO LTD's FEI number is 3040487740.

What types of violations has REYOUNG PHARCEUTICAL CO LTD received?

REYOUNG PHARCEUTICAL CO LTD has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about REYOUNG PHARCEUTICAL CO LTD come from?

All FDA import refusal data for REYOUNG PHARCEUTICAL CO LTD is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.